The sizeable difference in fold change for PRMT2, GAS6, and AKT3 indicate that TK1 expression may have an impact on these factors and in part explain the pathogenic phenotype we saw in HCC 1806 cells. This evidence concerns the gene AKT3 and hepatocellular carcinoma.